← Back to Clinical Trials
Recruiting NCT06822660

NCT06822660 Dreams or Implicite Memorization Under OFA

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06822660
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire Saint Pierre
Condition Implicite Memorization
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2024-11-25
Primary Completion 2025-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2024-11-25 with a primary completion date of 2025-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Dreams study is an observational study aimed at evaluating the incidence of connected awareness after intubation, intraoperative explicit and implicit memorization, and postoperative well-being in patients receiving general anesthesia without opioids. Outcomes The primary objective is the evaluation of the incidence of connected consciousness after induction of general anesthesia without opioids and intubation. The secondary objectives are: * Implicit and explicit memorization after intubation and during the procedure * Post-operative well-being Pain in the recovery room and in the room, assessed by VAS; * Total consumption of analgesics (paracetamol, diclofenac, tramadol): data collected during discharge * Level of satisfaction, assessed using the EVAN scale * Duration of hospitalization * Estimated first mobilization

Eligibility Criteria

Inclusion Criteria: * laparoscopic robotic surgery * ASA score 1 to 3 Exclusion Criteria: * neurological and psychiatric diseases * reflect memory disorders * head trauma * hearing disorders * past or current use of medications affecting the central nervous system.

Contact & Investigator

Central Contact

Florent Postal, Md

✉ florent.postal@stpierre-bru.be

📞 +32 470 044 986

Frequently Asked Questions

Who can join the NCT06822660 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Implicite Memorization. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06822660 currently recruiting?

Yes, NCT06822660 is actively recruiting participants. Contact the research team at florent.postal@stpierre-bru.be for enrollment information.

Where is the NCT06822660 trial being conducted?

This trial is being conducted at Brussels, Belgium.

Who is sponsoring the NCT06822660 clinical trial?

NCT06822660 is sponsored by Centre Hospitalier Universitaire Saint Pierre. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology